American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA

Jan Nolta

American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA

Research output: Contribution to journal › Article

Abstract

Cellular therapy is the medicine of the future. A new era is being rapidly ushered in, where the medical community may become less dependent upon the use of certain drugs for specific therapies, and more dependent upon prescribing and confidently using cellular therapy applications to enhance engraftment of transplanted hematopoietic stem cells, reduce the severity of GvHD, immunize against specific malignancies, and even to repair chronically or acutely damaged tissues and organs.

Original language	English (US)
Pages (from-to)	8-11
Number of pages	4
Journal	IDrugs
Volume	5
Issue number	1
State	Published - 2002
Externally published	Yes

ASJC Scopus subject areas

Pharmacology

Access to Document

Fingerprint Dive into the research topics of 'American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA'. Together they form a unique fingerprint.

Cite this

Nolta, J. (2002). American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA. IDrugs, 5(1), 8-11.

@article{6e9fe0a626de42a6a44299caef0e5170,

title = "American Society of Hematology 2001 - 43rd Annual Meeting: New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA",

abstract = "Cellular therapy is the medicine of the future. A new era is being rapidly ushered in, where the medical community may become less dependent upon the use of certain drugs for specific therapies, and more dependent upon prescribing and confidently using cellular therapy applications to enhance engraftment of transplanted hematopoietic stem cells, reduce the severity of GvHD, immunize against specific malignancies, and even to repair chronically or acutely damaged tissues and organs.",

author = "Jan Nolta",

year = "2002",

language = "English (US)",

volume = "5",

pages = "8--11",

journal = "IDrugs : the investigational drugs journal",

issn = "1369-7056",

publisher = "Current Drugs Ltd.",

number = "1",

}

TY - JOUR

T1 - American Society of Hematology 2001 - 43rd Annual Meeting

T2 - New developments in cell-based therapies: 7-11 December 2001, Orlando, FL, USA

AU - Nolta, Jan

PY - 2002

Y1 - 2002

N2 - Cellular therapy is the medicine of the future. A new era is being rapidly ushered in, where the medical community may become less dependent upon the use of certain drugs for specific therapies, and more dependent upon prescribing and confidently using cellular therapy applications to enhance engraftment of transplanted hematopoietic stem cells, reduce the severity of GvHD, immunize against specific malignancies, and even to repair chronically or acutely damaged tissues and organs.

AB - Cellular therapy is the medicine of the future. A new era is being rapidly ushered in, where the medical community may become less dependent upon the use of certain drugs for specific therapies, and more dependent upon prescribing and confidently using cellular therapy applications to enhance engraftment of transplanted hematopoietic stem cells, reduce the severity of GvHD, immunize against specific malignancies, and even to repair chronically or acutely damaged tissues and organs.

UR - http://www.scopus.com/inward/record.url?scp=0141673163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141673163&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0141673163

VL - 5

SP - 8

EP - 11

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 1

ER -